Listed pharmas recording weakened cash flow from operating activities decreased by 20%

Published: 2018-04-02 09:52:20

Updated: 2018-04-02 09:52:20

Listed pharmaceutical companies reported had a 20% decrease in cash flow from operating activities last year compared to 2015.

Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports(consolidated) 64 listed pharmaceutical companies submitted, their cash flow from operating activities was about KRW 1.008 trillion, decreased by 19.8% from KRW 1.2474 trillion. (holding and biotechnology compani...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.